Company CanSino Biologics Inc.

Equities

6185

CNE100003F01

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
15.92 HKD +0.89% Intraday chart for CanSino Biologics Inc. -5.91% -32.40%

Business Summary

CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Number of employees: 2,291

Sales per Business

HKD in Million2022Weight2023Weight Delta
Vaccine Products
100.0 %
1,203 100.0 % 395 100.0 % -67.20%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
99.1 %
945 78.8 % 378 99.1 % -60.01%
Foreign
0.9 %
254 21.2 % 3 0.9 % -98.63%

Managers

Managers TitleAgeSince
Founder 62 09-01-12
Founder 51 09-01-12
Chief Executive Officer 60 09-01-12
Founder 64 09-01-12
Director of Finance/CFO 43 21-05-31
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 61 18-04-30
Director/Board Member 42 12-05-31
Director/Board Member 61 10-12-31
Corporate Secretary 37 16-04-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 53 15-08-31
Chief Operating Officer 61 18-04-30
Founder 64 09-01-12
Director/Board Member 58 19-11-28
Chief Executive Officer 60 09-01-12
Founder 51 09-01-12
Director/Board Member 61 10-12-31
Chairman 45 19-06-27
Director/Board Member 42 12-05-31
Director/Board Member 59 19-11-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 115,278,999 0 500,000 ( 0.4337 %) 39.22 %
Stock B 1 132,670,900 97,253,029 ( 73.30 %) 0

Shareholders

NameEquities%Valuation
10,785,941 8.130 % 25 M $
Qiming Venture Partners Ltd.
5.666 %
7,516,538 5.666 % 18 M $
BlackRock Fund Advisors
2.174 %
2,884,200 2.174 % 7 M $
BlackRock Advisors (UK) Ltd.
0.6625 %
879,000 0.6625 % 2 M $
Bosera Asset Management Co., Ltd.
0.5457 %
724,000 0.5457 % 2 M $
Fullgoal Fund Management Co., Ltd.
0.5231 %
694,000 0.5231 % 2 M $
BlackRock (Netherlands) BV
0.5116 %
678,689 0.5116 % 2 M $
675,000 0.5088 % 2 M $
BlackRock Japan Co. Ltd.
0.4079 %
541,224 0.4079 % 1 M $
BlackRock Investment Management (UK) Ltd.
0.3156 %
418,662 0.3156 % 975 424 $
NameEquities%Valuation
China Merchants Fund Management Co., Ltd.
2.124 %
1,419,110 2.124 % 11 M $
670,148 1.003 % 5 M $
GF Fund Management Co., Ltd.
0.9101 %
608,076 0.9101 % 5 M $
Yinhua Fund Management Co., Ltd.
0.7856 %
524,909 0.7856 % 4 M $
China Southern Asset Management Co., Ltd.
0.7201 %
481,148 0.7201 % 4 M $
Tian Hong Asset Management Co., Ltd.
0.6997 %
467,537 0.6997 % 4 M $
Wanjia Asset Management Co., Ltd.
0.4059 %
271,200 0.4059 % 2 M $
Fullgoal Fund Management Co., Ltd.
0.3983 %
266,120 0.3983 % 2 M $
Western Leadbank Fund Management Co., Ltd
0.2414 %
161,271 0.2414 % 1 M $
China Asset Management Co., Ltd.
0.2339 %
156,294 0.2339 % 1 M $

Holdings

NameEquities%Valuation
670,148 1.00% 5,347,580 $

Company contact information

CanSino Biologics, Inc.

4/F, Room 401-420, Biomedical Park 185 South Avenue

300457, Tianjin

+86 022 5821 3600

http://www.cansinotech.com
address CanSino Biologics Inc.(6185)